Eurofins-Cerep SA
PAR:ALECR

Watchlist Manager
Eurofins-Cerep SA Logo
Eurofins-Cerep SA
PAR:ALECR
Watchlist
Price: 22 200 EUR 8.82% Market Closed
Market Cap: 111m EUR
Have any thoughts about
Eurofins-Cerep SA?
Write Note

Net Margin
Eurofins-Cerep SA

20%
Current
21%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20%
=
Net Income
9.2m
/
Revenue
46.2m

Net Margin Across Competitors

Country FR
Market Cap 111.9m EUR
Net Margin
20%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 196.3B USD
Net Margin
14%
Country US
Market Cap 170.3B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 36.7B USD
Net Margin
9%
Country US
Market Cap 26.4B USD
Net Margin
21%
Country US
Market Cap 23B USD
Net Margin
17%
Country US
Market Cap 22.3B USD
Net Margin
-36%
No Stocks Found

Eurofins-Cerep SA
Glance View

Market Cap
111.9m EUR
Industry
Life Sciences Tools & Services

Eurofins-Cerep SA engages in providing preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 211 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.

ALECR Intrinsic Value
20 976.22 EUR
Overvaluation 6%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20%
=
Net Income
9.2m
/
Revenue
46.2m
What is the Net Margin of Eurofins-Cerep SA?

Based on Eurofins-Cerep SA's most recent financial statements, the company has Net Margin of 20%.